quit brexit uk retail sore
thumb may miss
mani challeng see better upsid visibl
walgreen report anoth mix quarter highlight pressur
busi face even ep come consensu view
combin weak front end growth continu gross margin pressur weaken
fundament intern retail busi off-set sg benefit
includ today cost transform program share repurchas benefit
trend driven gross margin lower remain place believ recent
shift pbm contract away rebat could ultim lead anoth leg lower
pharmaci reimburs walgreen recent announc partnership could help
time particularli labcorp near-term basi see potenti
benefit outsid scope drive near-term valu share result reiter
rate under-perform lower po use
estim reduc cost cut alreadi model
reduc ep ep
reduct driven increment gross profit pressur intern retail
busi lower us front end growth off-set on-going sg cut note
long-term estim alreadi assum level cost cut today new plan
entir increment biggest swing factor estim would better
contribut variou partnership addit sg cut below-the-lin
upcom event catalyst
key focu investor gain increment comfort scope
financi contribut recent struck partnership increas labcorp
roll-out increas deliveri biggest near-term opportun view
separ addit prefer part relationship file buy could act
catalyst share anoth catalyst includ gener updat market growth
net dbt
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
walgreen follow complet rite
aid store acquisit largest global
pharmaci nearli store us
alon compani also oper intern
pharmaci busi primarili compos
boot pharmaci unit kingdom
allianc healthcar intern wholesal
distributor pharmaceut medic
product europ walgreen headquart
under-perform rate predic
market headwind competit dynam
exacerb concern around pend
amazon entri market core profit
dollar growth slow think limit visibl
creat challeng near-term stock
perform view range-bound
weak quarter
half retail pharmaci intern due weak uk balanc
due except event y/i comparison
retail pharmaci usa growth driven acquir store core growth
adjust sg increas due entir acquir store ex-
last year comp impact benefit hurrican
confirm constant-curr ep guidanc ep growth
currenc result advers impact compar
guidanc previous announc
expect ep back-end weight cost save come
save end third year
perform within divis
one-tim cost cash cost
still need valu busi model financi model
believ could provid templat primari care mani
cost save expect cost synergi region
much get reinvest busi
expect return
comfort around three year compani would like beat
margin recent relationships/partnership posit neg
impact core margin
put right product behind right expertis
unpack prescript growth quarter
pleas retent far anticip solid year part
overal same-stor sale
organ two compon overal store around
specialti busi grow
result divis long reimburs pressur
last uk compani off-set
walgreen lose share see reimburs
retail busi uk walgreen gain share
categori declin acceler due weak uk market
think variou partnership compani announc
point see increment financi partnership specif
fee partnership start manifest big enough
move needl oper profit
partnership signific contribut
directli
relat adjust oper incom
commentari relat pharmaceut brand inflat trend
less deflat gener
price object base ep multipl
five-year averag absolut basi around discount five-year
averag reflect view walgreen core retail pharmaci busi long-
term structur pressur must diversifi stabl busi line improv
upsid risk better expect gener save addit volum
econdisc/rit aid new partnership healthcar support long-term growth
contribut addit new partnership faster expect growth
prime relationship downsid risk po greater expect
prescript attrit part relationship integr risk
risk amazon anoth disrupt forc enter suppli chain market
lack avail attract capit deploy opportun
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
